-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Supportive Care in Myeloma – When Treating the Clone Alone Is Not Enough

Program: Education Program
Session: Newly Diagnosed Multiple Myeloma: Many Choices and More Questions
Hematology Disease Topics & Pathways:
Treatment Considerations, Adverse Events
Saturday, December 7, 2024, 2:00 PM-3:15 PM

Sonja Zweegman, MD, PhD

Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands

Disclosures: Zweegman: Sanofi: Membership on an entity's Board of Directors or advisory committees; BMS: Membership on an entity's Board of Directors or advisory committees; GSK: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees, Research Funding; Amgen: Membership on an entity's Board of Directors or advisory committees; Takeda: Research Funding; Oncopeptides: Membership on an entity's Board of Directors or advisory committees.

See more of: Newly Diagnosed Multiple Myeloma: Many Choices and More Questions
See more of: Education Program
<< Previous Presentation | Next Presentation